Morgan Stanley cuts Oatly stock price target on peer valuations By Investing.com

Morgan Stanley cut Oatly’s price target to $12.50 from $14.50 while keeping an Equalweight rating, highlighting lower peer multiples and rising capex concerns. Oatly beat revenue expectations by 6.4% with 8.1% organic sales growth and a 188 bps gross margin beat to 32%, but lowered adjusted EBITDA guidance to the low end of its prior range due to cost headwinds linked to developments in Iran. Management kept fiscal 2026 organic sales growth guidance unchanged and said it has not yet seen demand impact from the Middle East conflict.

Analysis

OTLY’s print is better read as a margin-quality story than a demand inflection: the business is getting operating leverage from supply-chain fixes and mix, but the market will likely keep discounting the equity until those gains prove durable through a full input-cost cycle. The debt load makes the equity a levered call option on execution, so even modest EBITDA slippage can overwhelm the “beats” narrative. In small-cap consumer staples, the rerating trigger is not one quarter of gross margin expansion; it’s two to three consecutive quarters showing that gross profit can outrun freight, ingredient, and FX noise.

The key second-order issue is competitive behavior. If Oatly’s volume recovery in North America is real, incumbents and private-label oat brands may respond with promotion, capping pricing power just as the company needs cleaner EBITDA conversion. That would shift the battleground from top-line growth to shelf-space economics, where smaller players often lose discipline and subsidize share with margin. Meanwhile, any geopolitical cost shock is a reminder that an ostensibly improving consumer brand can still be hostage to global logistics and commodity inputs, which matters more for a highly levered balance sheet than for an unlevered peer.

For MS, the downgrade is less about the target change and more about signaling that capex intensity is being penalized across the software/AI complex. Even when execution is solid, rising investment can compress near-term multiple support because investors start marking cash flow rather than revenue. That creates a valuation overhang for other large-cap beneficiaries of the same spend cycle if the market decides capex is outrunning monetization.

Key Decisions for Investors

• Avoid chasing OTLY on the release; wait 2-3 weeks for any post-earnings fade and look for a tighter entry only if management reiterates guidance without further EBITDA downside. Risk/reward is asymmetric only if the market stops extrapolating leverage risk.
• For higher-conviction longs, prefer a pair: long a profitable consumer staples name with cleaner balance sheets vs short OTLY as a relative-value hedge over 1-2 quarters. The thesis is that quality balance sheets will outperform levered turnaround stories if input costs re-accelerate.
• If willing to express a momentum fade in MS, consider a short-dated put spread on MS or a basket short of capex-sensitive large caps over the next 4-8 weeks. The setup works if the market continues to punish rising investment intensity despite good operating prints.
• Monitor OTLY for any sign of promotional activity in North America or margin giveback in Europe; if gross margin slips more than ~100 bps next quarter, exit any long thesis immediately because the equity likely de-rates faster than fundamentals adjust.